Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
Ramelius Resources Ltd (ASX:RMS) is a leading Western Australian gold producer and has reported encouraging numbers in the first half of fiscal year 2025 (H1 FY25). The company’s results were driven by high-grade ore production, operational efficiency, and elevated gold prices. Furthermore, on the …
Integral Diagnostics Limited (ASX:IDX) is an ASX-listed company that offers medical imaging services across Australia and New Zealand. In the first half of the financial year 2025 (H1FY25), the company recorded an 8% YoY revenue increase to AUD 249.4 million, supported by continued organic …
NEXTDC Limited (ASX:NXT) is an ASX-listed Data Centre-as-a-Service provider delivering critical power, security and connectivity solutions to global cloud platforms, enterprises, and government clients across Australia.
Melbourne-based health informatics firm Pro Medicus Limited (ASX:PME) offers a full range of medical imaging, software, and services to healthcare groups, hospitals and imaging centres. The company has a presence across Europe, North America and Australia. In the six months ended 31 December 2024 …
Life360 Inc. (ASX:360) is a provider of location-based tracking and messaging solutions for safety and coordination. In the full year ended 31 December 2024 (FY24), the company posted a 22% YoY increase in total revenue, reaching USD 371.5 million, up from USD 304.5 million …
Arafura Rare Earths Limited (ASX:ARU) is an Australian mineral exploration and development company that continues to cement its role in the rare earths sector through focused development of its Nolans Project in the Northern Territory.
Exchange Traded Funds (ETFs) are a convenient way to start building a balanced portfolio and it's no surprise that they are among the fastest-growing investment products worldwide.
Neuren Pharmaceuticals Limited (ASX:NEU) is an ASX-listed biopharmaceutical company, focusing on the development and commercialisation of novel treatments for neurological disorders. The company is making significant progress with its lead products, DAYBUE™ (trofinetide) and NNZ-2591.
The S&P/ASX200 closed sharply higher on Tuesday, rising 166.70 points or 2.27% to 7,510.00, after hitting a new 52-week low on Monday after China retaliated against US tariffs. Today’s gains in the Australian equity benchmark were supported by broad-based buying across the sector, with …
Following a recent sharp downturn in the Australian share market, marked by a nearly 5% drop in the ASX 200 within a week, investors are rethinking their strategies in search of resilience and reliable returns. The Australian share market offers several dividend-paying stocks for …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…